APTO•benzinga•
CORRECTION: HC Wainwright & Co. Reiterates Buy on Aptose Biosciences, Maintains $2 Price Target (Firm Name Change From RBC To HC Wainwright & Co.)
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 12, 2025 by benzinga